490 related articles for article (PubMed ID: 33121471)
41. Chromoendoscopy with a Standard-Resolution Colonoscope for Evaluation of Rectal Aberrant Crypt Foci.
Kowalczyk M; Siermontowski P; Mucha D; Ambroży T; Orłowski M; Zinkiewicz K; Kurpiewski W; Paśnik K; Kowalczyk I; Pedrycz A
PLoS One; 2016; 11(2):e0148286. PubMed ID: 26886097
[TBL] [Abstract][Full Text] [Related]
42. [Aberrant crypt foci as biomarkers in chemoprevention for colorectal cancer].
Katsuki S; Oui M; Takayama T; Takahashi Y; Shuichi N; Niitsu Y
Nihon Geka Gakkai Zasshi; 1998 Jun; 99(6):379-84. PubMed ID: 9695076
[TBL] [Abstract][Full Text] [Related]
43. Biology and diagnosis of aberrant crypt foci.
Lopez-Ceron M; Pellise M
Colorectal Dis; 2012 Apr; 14(4):e157-64. PubMed ID: 22182185
[TBL] [Abstract][Full Text] [Related]
44. The Effect of Smoking on the Number and Type of Rectal Aberrant Crypt Foci (ACF)-First Identifiable Precursors of Colorectal Cancer (CRC).
Kowalczyk M; Klepacki Ł; Zieliński E; Kurpiewski W; Zinkiewicz K; Dyśko Ł; Pesta W
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375262
[TBL] [Abstract][Full Text] [Related]
45. Association between factors associated with colorectal cancer and rectal aberrant crypt foci in humans.
Ezuka A; Sakai E; Kawana K; Nagase H; Kakuta Y; Uchiyama S; Ohkubo H; Higurashi T; Nonaka T; Endo H; Takahashi H; Nakajima A
Oncol Lett; 2015 Dec; 10(6):3689-3695. PubMed ID: 26788192
[TBL] [Abstract][Full Text] [Related]
46. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
47. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).
Burn J; Mathers J; Bishop DT
Recent Results Cancer Res; 2013; 191():157-83. PubMed ID: 22893205
[TBL] [Abstract][Full Text] [Related]
48. Effect of Low-dose and Standard-dose Aspirin on PGE
Drew DA; Schuck MM; Magicheva-Gupta MV; Stewart KO; Gilpin KK; Miller P; Parziale MP; Pond EN; Takacsi-Nagy O; Zerjav DC; Chin SM; Mackinnon Krems J; Meixell D; Joshi AD; Ma W; Colizzo FP; Carolan PJ; Nishioka NS; Staller K; Richter JM; Khalili H; Gala MK; Garber JJ; Chung DC; Yarze JC; Zukerberg L; Petrucci G; Rocca B; Patrono C; Milne GL; Wang M; Chan AT
Cancer Prev Res (Phila); 2020 Oct; 13(10):877-888. PubMed ID: 32718943
[TBL] [Abstract][Full Text] [Related]
49. Chemopreventive Potential of 2,3,5,4'-Tetrahydroxystilbene-2-O-
Lin CL; Jeng JH; Wu CC; Hsieh SL; Huang GC; Leung W; Lee CT; Chen CY; Lee CH
Biomed Res Int; 2017; 2017():3634915. PubMed ID: 29238715
[TBL] [Abstract][Full Text] [Related]
50. PPARgamma Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study.
Takahashi H; Hosono K; Uchiyama T; Sugiyama M; Sakai E; Endo H; Maeda S; Schaefer KL; Nakagama H; Nakajima A
PPAR Res; 2010; 2010():. PubMed ID: 20814432
[TBL] [Abstract][Full Text] [Related]
51. Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer Risk.
Quintanilla I; López-Cerón M; Jimeno M; Cuatrecasas M; Zabalza M; Moreira L; Alonso V; Rodríguez de Miguel C; Muñoz J; Castellvi-Bel S; Llach J; Castells A; Balaguer F; Camps J; Pellisé M
Clin Transl Gastroenterol; 2019 Jun; 10(6):e00047. PubMed ID: 31136360
[TBL] [Abstract][Full Text] [Related]
52. Identification of preneoplastic lesions as mucin-depleted foci in patients with sporadic colorectal cancer.
Sakai E; Morioka T; Yamada E; Ohkubo H; Higurashi T; Hosono K; Endo H; Takahashi H; Takamatsu R; Cui C; Shiozawa M; Akaike M; Samura H; Nishimaki T; Nakajima A; Yoshimi N
Cancer Sci; 2012 Jan; 103(1):144-9. PubMed ID: 22017323
[TBL] [Abstract][Full Text] [Related]
53. A randomized trial of aspirin to prevent colorectal adenomas.
Baron JA; Cole BF; Sandler RS; Haile RW; Ahnen D; Bresalier R; McKeown-Eyssen G; Summers RW; Rothstein R; Burke CA; Snover DC; Church TR; Allen JI; Beach M; Beck GJ; Bond JH; Byers T; Greenberg ER; Mandel JS; Marcon N; Mott LA; Pearson L; Saibil F; van Stolk RU
N Engl J Med; 2003 Mar; 348(10):891-9. PubMed ID: 12621133
[TBL] [Abstract][Full Text] [Related]
54. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
Cole BF; Logan RF; Halabi S; Benamouzig R; Sandler RS; Grainge MJ; Chaussade S; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):256-66. PubMed ID: 19211452
[TBL] [Abstract][Full Text] [Related]
55. Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.
Hosono K; Endo H; Takahashi H; Sugiyama M; Uchiyama T; Suzuki K; Nozaki Y; Yoneda K; Fujita K; Yoneda M; Inamori M; Tomatsu A; Chihara T; Shimpo K; Nakagama H; Nakajima A
Mol Carcinog; 2010 Jul; 49(7):662-71. PubMed ID: 20564343
[TBL] [Abstract][Full Text] [Related]
56. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs.
Pereira MA
Adv Exp Med Biol; 1999; 470():55-63. PubMed ID: 10709674
[TBL] [Abstract][Full Text] [Related]
57. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
58. Prevention and intervention trials for colorectal cancer.
Komiya M; Fujii G; Takahashi M; Iigo M; Mutoh M
Jpn J Clin Oncol; 2013 Jul; 43(7):685-94. PubMed ID: 23613189
[TBL] [Abstract][Full Text] [Related]
59. A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis.
Burn J; Bishop DT; Chapman PD; Elliott F; Bertario L; Dunlop MG; Eccles D; Ellis A; Evans DG; Fodde R; Maher ER; Möslein G; Vasen HF; Coaker J; Phillips RK; Bülow S; Mathers JC;
Cancer Prev Res (Phila); 2011 May; 4(5):655-65. PubMed ID: 21543343
[TBL] [Abstract][Full Text] [Related]
60. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans.
Rudolph RE; Dominitz JA; Lampe JW; Levy L; Qu P; Li SS; Lampe PD; Bronner MP; Potter JD
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):605-8. PubMed ID: 15767337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
